To put it in perspective:
2018 Epichem External Revenue $2,890,000 NPBT $10k
2019 Epichem External Revenue $3,670,000 NPBT $390k
2020 Epichem Forecast Revenue up $500k to $4.2m, now $3.3m
The contract loss hurts our run but still trending ok. The non-renewed Unity contract of around $900k pa remains offset by about $500k of new 2020 work. I expect the main role of Epichem's new CEO's is to both diversify and boost total revenue. An early plus and minus ... too early to mark at the moment.
Ann: Epichem Awarded One-Year Contract Extension from DNDi, page-9
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $199.9K | 1.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 457971 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 1207 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |